They can also make sure that the level of dosage, frequency of use, and delivery of the medication, render optimal results with minimized side effects
Drug companies began developing GLP-1 drugs to treat diabetes in the early 1990s, and the first of them reached clinics in 2005
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
The cost of treatment depends on the treatment dosage, with patients on low-dose Tirzepatide (5mg per week) spending less than patients on high-dose Tirzepatide (10-15mg per week)
Severe ASD has been linked to elevated levels of IL-1 and IL-4 in the neonatal blood (Theoharides et al., 2016), and increased serum levels of IL-1 and IL-6 compared to control groups ( Recent data support findings that immune cells activity in ASD subjects is compromised, with amplified inflammatory signaling and reactivity of immune cells such as B-cells, neutrophils and monocytes (Majerczyk et al., 2022)